Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury

Trial Profile

Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury

Completed
Phase of Trial: Phase II/III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Sertraline (Primary)
  • Indications Affective disorders; Anxiety disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2016 Primary endpoint (Time to Onset of Diagnostic and Statistical Manual (DSM) IV Defined Mood and Anxiety Disorders Associated With Traumatic Brain Injury (TBI)), has been met, accoding to Results published in the JAMA Psychiatry.
    • 14 Sep 2016 Results published in the JAMA Psychiatry
    • 20 Jan 2010 Planned number of patients changed from 45 to 104 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top